TTK Healthcare (TTKHLTCARE) | Stock Overview & Key Data
TTK Healthcare Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,893.95 on September 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TTK Healthcare
TTKHLTCARE
|
13.01B Small-cap | 5.08% | -0.46% | 3.55% | -16.02% | -9.96% | -26.60% | -29.56% | 32.78% | -3.63% | 114.57% | 214.42% |
|
GlaxoSmithKline
GLAXO
|
422.67B Large-cap | -4.26% | -7.01% | -13.72% | -13.28% | -11.03% | -33.00% | 59.61% | 52.50% | -37.55% | -7.71% | 294.29% |
|
Pfizer
PFIZER
|
218.82B Large-cap | -2.74% | -3.52% | -8.08% | -9.61% | -8.16% | -18.08% | 19.42% | -11.38% | 144.66% | 248.17% | 442.50% |
|
Senores
SENORES
|
41.04B Small-cap | -10.53% | 15.57% | 34.92% | 30.17% | 25.05% | 114.17% | 95.52% | 95.52% | 95.52% | 95.52% | 95.52% |
|
Sms Pharmaceuticals
SMSPHARMA
|
37.15B Small-cap | -3.27% | -10.39% | -1.75% | 16.84% | 16.11% | 39.48% | 332.38% | 129.70% | 316.06% | 1,838.32% | 1,027.14% |
|
NGL Fine-Chem
NGLFINE
|
13.81B Small-cap | -5.86% | 17.50% | 10.50% | 100.29% | 90.07% | 144.63% | 92.90% | 49.02% | 49.02% | 49.02% | 49.02% |
Ownership & Short Interest
Calculate Your TTK Healthcare Investment Returns
Long-Term Investment Performance Analysis
TTK Healthcare stock price in May 2016 was ₹925.40, A ₹1,000.00 lump sum investment in TTK Healthcare made 10 years ago would be worth approximately ₹990.65 today, representing a negative return of -0.93%. This translates to an annualized return (CAGR) of -0.09%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is TTKHLTCARE's 52-week high and low?
- In the last 52 weeks, TTK Healthcare reached a high of ₹1,398.90 (on July 14, 2025) and a low of ₹735.00 (on March 30, 2026).
- What is the market cap and P/E ratio for TTKHLTCARE?
- Curious about TTK Healthcare's size and valuation? Its market capitalization stands at 13.01B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.64, and the forward P/E (looking ahead) is N/A.
- Does TTKHLTCARE pay dividends? If so, what's the yield?
- Yes, TTK Healthcare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.74%, and the company has paid an average of ₹13.33 per share annually over the past 3 years.
- Who are TTK Healthcare's main competitors or similar companies to consider before investing?
When looking at TTK Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO422.67B Healthcare Drug Manufacturers - General -33.00% 59.61% Pfizer
PFIZER218.82B Healthcare Drug Manufacturers - General -18.08% 19.42% Senores
SENORES41.04B Healthcare Drug Manufacturers - General 114.17% 95.52% Sms Pharmaceuticals
SMSPHARMA37.15B Healthcare Drug Manufacturers - General 39.48% 332.38% NGL Fine-Chem
NGLFINE13.81B Healthcare Drug Manufacturers - General 144.63% 92.90% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for TTK Healthcare Ltd? (e.g., ROE, Debt/Equity)
- To get a sense of TTK Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.67%, the Debt to Equity ratio from the most recent quarter is 2.47, and its Gross Profit Margin stands at 53.36%.
- What is the recent revenue and earnings growth for TTKHLTCARE?
- Looking at TTK Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.20%, and quarterly earnings saw a YoY growth of -37.10%.
- How much of TTKHLTCARE stock is held by insiders and institutions?
- Wondering who owns TTK Healthcare stock? Company insiders (like executives and directors) hold about 75.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.89%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.